Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Determinants of cancer therapy in elderly patients
James S. Goodwin
, William C. Hunt
, Jonathan M. Samet
Research output
:
Contribution to journal
›
Article
›
peer-review
224
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Determinants of cancer therapy in elderly patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Elderly Patients
100%
Definitive Therapy
100%
Cancer Therapy
100%
Mental Status
100%
Comorbidity
66%
Functional Status
66%
New Mexico
66%
Advanced Age
66%
Radiation Therapy
66%
Low Physical Activity
66%
Cancer Treatment
33%
Socioeconomic Status
33%
Prostate Cancer
33%
Tumor Registry
33%
Colorectal Cancer
33%
Old Age
33%
Medical Conditions
33%
Multivariate Analysis
33%
Activities of Daily Living
33%
Breast
33%
Social Support
33%
Significant Predictors
33%
Cognitive Status
33%
Explanatory Variables
33%
Univariate Analysis
33%
Limited Access
33%
Treatment Information
33%
Older Patients with Cancer
33%
Adult Cancer
33%
Definitive Surgery
33%
Non-medical
33%
Transportation Physical Activity
33%
Poor Social Support
33%
Medicine and Dentistry
Cancer Therapy
100%
Mental Health
100%
Elderly Patient
100%
Physical Activity
66%
Functional Status
66%
Social Support
66%
Comorbidity
66%
Radiation Therapy
66%
Malignant Neoplasm
33%
Neoplasm
33%
Socioeconomic Status
33%
Prostate Cancer
33%
Colorectal Carcinoma
33%
Univariate Analysis
33%
Advanced Cancer
33%
Multivariate Analysis
33%
Nursing and Health Professions
Cancer Therapy
100%
Mental Health
100%
Elderly Patient
100%
Social Support
66%
Functional Status
66%
Comorbidity
66%
Radiotherapy
66%
Physical Activity
66%
Malignant Neoplasm
33%
Neoplasm
33%
Socioeconomic Status
33%
Univariate Analysis
33%
Prostate Cancer
33%
Advanced Cancer
33%
Colorectal Carcinoma
33%
Multivariate Analysis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Functional Status
50%
Comorbidity
50%
Prostate Cancer
25%
Colorectal Carcinoma
25%
Neoplasm
25%
Advanced Cancer
25%